Investigation of the Effect of Intravenous Lidocaine Infusion on Postoperative Pain Treatment and Bowel Function in Robotic Bowel Surgery
Randomized Double Blind Prospective Investigation of the Effect of Intravenous Lidocaine Infusion on Postoperative Pain Treatment and Bowel Function in Robotic Bowel Surgery
2 other identifiers
interventional
60
1 country
1
Brief Summary
Single center double blind randomised controlled trial. 60 subjects. Giving lidocaine IV or saline to patients due to robot assisted colorectal surgery. Primary outcome is cumulative morphine consumption at 24 hours.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_4
Started Feb 2016
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 2, 2016
CompletedFirst Submitted
Initial submission to the registry
February 3, 2017
CompletedFirst Posted
Study publicly available on registry
February 7, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 19, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
April 19, 2017
CompletedSeptember 20, 2017
September 1, 2017
1.2 years
February 3, 2017
September 18, 2017
Conditions
Outcome Measures
Primary Outcomes (1)
Reduction in morphine consumption
PCA morphine added to PN (per necessitae) morphine, cumulated
over the first 24 hours
Secondary Outcomes (5)
PONV
up to 72 hours
Reduction in morphine consumption
over the first 72hours
Use of antiemetics postoperative
first 72 hours
Time to bowel function
first 72 hours
time to discharge
up to 72 hours
Study Arms (2)
Lidocain
EXPERIMENTALPatient gets the experimental treatment with IV lidocain 0,5mg/ml, 1,5mg/kg bolus before induction of anesthesia, after that infusion of 1,5mg/kg/h is started and continued until 2 hours after end of surgery.
Control
PLACEBO COMPARATORPatients get the same amount in ml and duration as if it was the experimental arm. Only in this arm it is isotonic saline instead.
Interventions
Eligibility Criteria
You may qualify if:
- all patients due to robotic laparoscopic colorectal surgery, \> 18years of age, danish speaking
You may not qualify if:
- allergy to lidocain or amid local analgetics, atrioventricular blok, liver- and/or kidney failure, chronic use of opioids or NSAIDS, pregnancy, breastfeeding women, treatment with betablockers, porphyria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Odense Universitetshospital
Odense, 5000, Denmark
Related Publications (1)
Herzog J, Schou M, Jensen KM, Lauridsen JT, Jensen AG. A randomised controlled trial of lidocaine infusion on post-operative opioid consumption in patients undergoing robotic colorectal surgery. Dan Med J. 2020 Jan;67(1):A06190342.
PMID: 31908254DERIVED
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- Pharmacy provides the research medicine, it is not possible to see a difference. The envelopes are "encrypted". The randomization will only be broken in the end.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- M.D.
Study Record Dates
First Submitted
February 3, 2017
First Posted
February 7, 2017
Study Start
February 2, 2016
Primary Completion
April 19, 2017
Study Completion
April 19, 2017
Last Updated
September 20, 2017
Record last verified: 2017-09
Data Sharing
- IPD Sharing
- Will not share